Back to search
FDAFDA · Food and drugs·Recall number D-0182-2026

Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, LLC, NDC 63323-739-11 (unit of use), 63323-739-12 (unit of sale).

Published December 3, 2025 · Recall initiated: November 6, 2025

Summary

FDA records drug Class I recall D-0182-2026, published December 3, 2025 and initiated November 6, 2025. Recalling firm: Fresenius Kabi USA, LLC; Status: Ongoing; Reported quantity: 2,199,850 vials; Lot: Lot #: 6133156, 6133194, Exp Date: 08/2026; 6133388, Exp Date: 10/2026. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.

What to do

Voluntary: Firm initiated · Letter

Get an email if FAMOTIDINE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
FAMOTIDINE
Manufacturer
Fresenius Kabi USA, LLC
Distributor
Nationwide within the United States as well as AK, HI, and PR.
UPC
0363323739119
Lot
Lot #: 6133156, 6133194, Exp Date: 08/2026; 6133388, Exp Date: 10/2026.
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, LLC, NDC 63323-739-11 (unit of use), 63323-739-12 (unit of sale). recalled?

Yes. FDA published recall D-0182-2026 on December 3, 2025. Reported hazard: Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: FAMOTIDINE. UPC: 0363323739119.